LARIDA Trademark

Trademark Overview

On Thursday, December 4, 2014, a trademark application was filed for LARIDA with the United States Patent and Trademark Office. The USPTO has given the LARIDA trademark a serial number of 86470937. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, February 12, 2018. This trademark is owned by Teva Pharmaceutical Industries, Ltd.. The LARIDA trademark is filed in the Pharmaceutical Products category with the following description:

Antiretroviral drug for the treatment of HIV-1 infection
larida

General Information

Serial Number86470937
Word MarkLARIDA
Filing DateThursday, December 4, 2014
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, February 12, 2018
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 12, 2015

Trademark Statements

Goods and ServicesAntiretroviral drug for the treatment of HIV-1 infection

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, December 10, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameTeva Pharmaceutical Industries, Ltd.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressJerusalem 91010
IL
Party NameTeva Pharmaceutical Industries, Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressJerusalem 91010
IL

Trademark Events

Event DateEvent Description
Monday, February 12, 2018ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, February 12, 2018ABANDONMENT - NO USE STATEMENT FILED
Saturday, July 1, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 29, 2017EXTENSION 4 GRANTED
Thursday, June 29, 2017EXTENSION 4 FILED
Thursday, June 29, 2017TEAS EXTENSION RECEIVED
Saturday, January 7, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 5, 2017EXTENSION 3 GRANTED
Thursday, January 5, 2017EXTENSION 3 FILED
Thursday, January 5, 2017TEAS EXTENSION RECEIVED
Saturday, July 2, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 30, 2016EXTENSION 2 GRANTED
Thursday, June 30, 2016EXTENSION 2 FILED
Thursday, June 30, 2016TEAS EXTENSION RECEIVED
Thursday, January 7, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 5, 2016EXTENSION 1 GRANTED
Tuesday, January 5, 2016EXTENSION 1 FILED
Tuesday, January 5, 2016TEAS EXTENSION RECEIVED
Tuesday, July 7, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, June 1, 2015APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, June 1, 2015TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, May 12, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 12, 2015PUBLISHED FOR OPPOSITION
Wednesday, April 22, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, March 18, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 17, 2015ASSIGNED TO EXAMINER
Wednesday, December 10, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, December 8, 2014NEW APPLICATION ENTERED IN TRAM

Related Keywords

larida infection treatment drug antiretroviral